DOJ Granted Leave To Join High Court Arguments Over Patent On-Sale Dates
WASHINGTON, D.C. — The same day that Teva Pharmaceuticals USA Inc. filed its respondent brief in a U.S. Supreme Court dispute over what triggers the on-sale bar in the patent application...To view the full article, register now.
Already a subscriber? Click here to view full article